Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
biotech
boston blog main
8
×
boston top stories
clinical trials
8
×
life sciences
national blog main
boston
fda
national top stories
deals
medical device
biotech ipos
investing
ipo
multiple myeloma
national
new york
new york blog main
new york top stories
non-hodgkin lymphoma
novartis
perceptive advisors
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
renaissance capital
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
software
startups
480 biomedical
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
alirocumab
ally bridge group
alnylam pharmaceuticals
What
company
8
×
ipo
medicines
million
developing
drug
new
raised
raises
biotech
brings
firms
genetic
life
public
science
tests
therapeutics
way
acquire
agreed
aiming
analysis
bacteria
billion
bio
biology
biotechs
bioworks
blood
bring
broader
called
cancer
cash
cholesterol
chose
clinical
close
closed
Language
unset
Current search:
photo
×
" boston blog main "
×
company
×
" clinical trials "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence